Literature DB >> 28666672

Radius Core Decompression for Kienböck Disease Stage IIIA: Outcomes at 13 Years Follow-Up.

Pablo De Carli1, Ezequiel Ernesto Zaidenberg2, Veronica Alfie1, Agustin Donndorff1, Jorge Guillermo Boretto1, Gerardo Luis Gallucci1.   

Abstract

PURPOSE: This study was designed to analyze the long-term clinical and radiological outcomes of a series of patients with Kienböck disease stage IIIA treated with radius core decompression.
METHODS: This retrospective study included 15 patients with Kienböck disease (Lichtman stage IIIA) who underwent distal radius metaphyseal core decompression between 1998 and 2005 and who were followed-up for at least 10 years. At the last follow-up, the patients were evaluated for wrist range of motion and grip strength. The overall results were evaluated by the modified Mayo wrist score and visual analog scale pain score. We also compared the radiological changes between the preoperative and the final follow-up in their Lichtman classification and the modified carpal height ratio.
RESULTS: The mean follow-up period was 13 years (range, 10-18 years). Based on the modified Mayo wrist score, clinical results were excellent in 6 patients, good in 8 patients, and poor in 1 patient who required a proximal row carpectomy as revision surgery. The mean preoperative pain according to the visual analog scale was 7 (range, 6-10) and was 1.2 (range, 0-6) at the final follow-up. Compared with the opposite side, the average flexion/extension arc was 77% and the grip strength was 80%. All patients, except 1, returned to their original employment. At the final follow-up, 3 patients had decreased modified carpal height ratio, 12 remained unchanged. Radiographic disease progression according to the Lichtman classification to stages IIIB to IV occurred in only 2 wrists. There were no complications related to the core decompression.
CONCLUSIONS: In this limited series, the radius core decompression demonstrated favorable long-term results and could be considered as a surgical alternative for stage IIIA of Kienböck disease. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
Copyright © 2017 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kienböck disease; avascular necrosis; core decompression; long term; lunate

Mesh:

Year:  2017        PMID: 28666672     DOI: 10.1016/j.jhsa.2017.05.017

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  7 in total

1.  Treatment of Stages IIIA and IIIB in Kienbock's Disease: A Systematic Review.

Authors:  Patrick Q Wang; Bogdan A Matache; Ruby Grewal; Nina Suh
Journal:  J Wrist Surg       Date:  2020-09-14

2.  Metaphyseal Core Decompression and Anterograde Fixation for Scaphoid Proximal Pole Fracture Nonunion without Avascular Necrosis.

Authors:  Ignacio Rellan; Gerardo Luis Gallucci; Jorge Guillermo Boretto; Agustin Guillermo Donndorff; Ezequiel Ernesto Zaidenberg; Pablo De Carli
Journal:  J Wrist Surg       Date:  2019-07-11

3.  Clinical Outcomes of Patients with Stage II and IIIA Kienböck's Disease After Undergoing Conservative Management.

Authors:  Jae-Hoo Lee; JangWon Son; Min-Jong Park
Journal:  Indian J Orthop       Date:  2021-07-07       Impact factor: 1.033

4.  Analyzing Chronological Change in Postoperative Magnetic Resonance Imaging Results in Patients With Kienböck's Disease by Using an Original Grading System.

Authors:  Takeshi Ogawa; Akira Ikumi; Sho Kohyama; Yuki Hara; Yuichi Yoshii; Naoyuki Ochiai; Masashi Yamazaki
Journal:  Cureus       Date:  2022-04-16

Review 5.  [Treatment of necrosis of the lunate bone].

Authors:  K Kalb; J van Schoonhoven; J Windolf; T Pillukat
Journal:  Unfallchirurg       Date:  2018-05       Impact factor: 1.000

Review 6.  Recent Advances in Assessment and Treatment in Kienböck's Disease.

Authors:  Karol Chojnowski; Mikołaj Opiełka; Miłosz Piotrowicz; Bartosz Kamil Sobocki; Justyna Napora; Filip Dąbrowski; Maciej Piotrowski; Tomasz Mazurek
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

7.  Clinical outcomes of nonsurgical treatment for Preiser disease.

Authors:  Yuji Tomori; Mitsuhiko Nanno; Shinro Takai
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.